Aydilek Dağdeviren Çakır
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aydilek Dağdeviren Çakır has a total of 150 co-authors. Here are the top co-authors by number of shared publications:
- Olcay Evliyaoğlu
Department of Pediatric Endocrinology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey
13 shared publications - Oya Ercan
Department of Pediatric Endocrinology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Türkiye
10 shared publications - Bahar Özcabı
Acibadem Atasehir Hospital, Division of Pediatric Endocrinology, Istanbul, Türkiye
7 shared publications Hande Turan
Department of Pediatric Endocrinology, İstanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, İstanbul, Turkey
7 shared publications- Hande Turan
Department of Pediatric Endocrinology, Cerrahpaşa Faculty of Medicine, Istanbul University-Cerrahpaşa, Istanbul, Türkiye
6 shared publications Oya Ercan
Department of Pediatric Endocrinology, Istanbul University-Cerrahpasa, Cerrahpasa Faculty of Medicine, Istanbul, Türkiye
6 shared publications
Latest Publications
- 24 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 887
Serum Netrin-1 and ultrasonographic hepatic steatosis severity in obese children and adolescents with metabolic dysfunction–associated steatotic liver disease: a preliminary study
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a frequent hepatic complication of pediatric obesity, yet non-invasive circulating biomarkers associated with ultrasonographic steatosis severity remain limited. Netrin-1 is an immunometabolic regulator implicated in obesity-related inflammation and lipid metabolism, but prospective pediatric data in MASLD are scarce. In this preliminary prospective case–control study, 44 children and adolescents with obesity-related MASLD and 44 age- and sex-matched healthy controls with normal BMI were enrolled. Hepatic steatosis was assessed by ultrasonography, and serum Netrin-1 concentrations were measured by ELISA. Associations with ultrasonographic steatosis grade were evaluated using regression analyses, and discriminatory performance for moderate-to-severe ultrasonographic steatosis, defined as grades 2–3, was explored by receiver operating characteristic (ROC) analysis. Serum Netrin-1 concentrations were significantly higher in children and adolescents with obesity-related MASLD than in healthy controls with normal BMI (633.9 vs 302.0 pg/mL; p < 0.001). Within the MASLD group, Netrin-1 concentrations were higher in participants with grade 2–3 steatosis than in those with grade 1 steatosis (828.9 vs 594.7 pg/mL; p < 0.001). Netrin-1 correlated positively with alanine aminotransferase (ρ = 0.669; p < 0.001). ROC analysis showed good discriminatory performance for moderate-to-severe ultrasonographic steatosis (AUC 0.827; 95% CI 0.699–0.955). Conclusion: These preliminary findings suggest that serum Netrin-1 may represent an exploratory complementary biomarker candidate associated with ultrasonographic steatosis severity in pediatric MASLD. Larger multicenter studies including children and adolescents with obesity but without steatosis, together with quantitative imaging-based assessment, are required to validate these associations and determine the incremental clinical value of serum Netrin-1. What is Known: • Pediatric MASLD lacks validated non-invasive circulating biomarkers for assessing hepatic steatosis severity. • Netrin-1 is an immunometabolic mediator implicated in obesity-related inflammation and lipid metabolism, but pediatric data in MASLD are scarce. What is New: • In this preliminary prospective case–control study, serum Netrin-1 concentrations were higher in children and adolescents with obesity-related MASLD and were higher in those with grade 2–3 ultrasonographic steatosis than in those with grade 1 steatosis. • Serum Netrin-1 showed good exploratory discriminatory performance for moderate-to-severe ultrasonographic steatosis, suggesting that it may represent a complementary biomarker candidate requiring validation in larger independent pediatric cohorts.
- 24 October 2026
- Published by Springer Nature in European Journal of Pediatrics
- Vol. 185 (11) , 887
Serum Netrin-1 and ultrasonographic hepatic steatosis severity in obese children and adolescents with metabolic dysfunction–associated steatotic liver disease: a preliminary study
Metabolic dysfunction–associated steatotic liver disease (MASLD) is a frequent hepatic complication of pediatric obesity, yet non-invasive circulating biomarkers associated with ultrasonographic steatosis severity remain limited. Netrin-1 is an immunometabolic regulator implicated in obesity-related inflammation and lipid metabolism, but prospective pediatric data in MASLD are scarce. In this preliminary prospective case–control study, 44 children and adolescents with obesity-related MASLD and 44 age- and sex-matched healthy controls with normal BMI were enrolled. Hepatic steatosis was assessed by ultrasonography, and serum Netrin-1 concentrations were measured by ELISA. Associations with ultrasonographic steatosis grade were evaluated using regression analyses, and discriminatory performance for moderate-to-severe ultrasonographic steatosis, defined as grades 2–3, was explored by receiver operating characteristic (ROC) analysis. Serum Netrin-1 concentrations were significantly higher in children and adolescents with obesity-related MASLD than in healthy controls with normal BMI (633.9 vs 302.0 pg/mL; p < 0.001). Within the MASLD group, Netrin-1 concentrations were higher in participants with grade 2–3 steatosis than in those with grade 1 steatosis (828.9 vs 594.7 pg/mL; p < 0.001). Netrin-1 correlated positively with alanine aminotransferase (ρ = 0.669; p < 0.001). ROC analysis showed good discriminatory performance for moderate-to-severe ultrasonographic steatosis (AUC 0.827; 95% CI 0.699–0.955). Conclusion: These preliminary findings suggest that serum Netrin-1 may represent an exploratory complementary biomarker candidate associated with ultrasonographic steatosis severity in pediatric MASLD. Larger multicenter studies including children and adolescents with obesity but without steatosis, together with quantitative imaging-based assessment, are required to validate these associations and determine the incremental clinical value of serum Netrin-1. What is Known: • Pediatric MASLD lacks validated non-invasive circulating biomarkers for assessing hepatic steatosis severity. • Netrin-1 is an immunometabolic mediator implicated in obesity-related inflammation and lipid metabolism, but pediatric data in MASLD are scarce. What is New: • In this preliminary prospective case–control study, serum Netrin-1 concentrations were higher in children and adolescents with obesity-related MASLD and were higher in those with grade 2–3 ultrasonographic steatosis than in those with grade 1 steatosis. • Serum Netrin-1 showed good exploratory discriminatory performance for moderate-to-severe ultrasonographic steatosis, suggesting that it may represent a complementary biomarker candidate requiring validation in larger independent pediatric cohorts.
- 15 September 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
Baseline and 3-Year Follow-Up Changes in Retinal Neurovascular Structures Assessed by OCT and OCTA in Pediatric Type 1 Diabetes Without Retinopathy
Purpose: To investigate longitudinal changes in retinal neurovascular components over a 3-year period using optical coherence tomography (OCT) and OCT angiography (OCTA) in pediatric and adolescent individuals diagnosed with type 1 diabetes mellitus (DM) but without signs of diabetic retinopathy (DR). Methods: Individuals with type 1 DM and no clinical signs of DR were evaluated between May and September 2022. Quantitative evaluation was performed on neurovascular components of the retina in both the macular and peripapillary regions. Data from the previous 3 years (Group 1) were compared with current data (Group 2). Relationships between pubertal stage, duration of diabetes, and glycosylated hemoglobin (HbA 1c ) levels were examined. Results: The study included 92 eyes from 46 participants diagnosed with type 1 DM. Group 2 had significantly lower vessel densities in the foveal and parafoveal superficial capillary plexus and deep capillary plexus than Group 1. However, central foveal thickness (CFT), inner retinal thickness, peripapillary retinal nerve fiber layer thickness, and nasal inferior disc-vessel density were significantly higher in Group 2. A significant relationship was found between pubertal stage and vessel densities in both the superficial capillary plexus and optic disc regions. HbA 1c levels and diabetes duration correlated with the foveal avascular zone area and superficial capillary plexus/deep capillary plexus-vessel densities. Conclusions: Initially, the peripapillary microvascular structure is more affected than the macula in type 1 DM. However, after 3 years, microvascular macular decline becomes more prominent. Additionally, foveal retinal thickness and peripapillary retinal nerve fiber layer thickness were significantly increased.
- 15 September 2026
- Published by SAGE Publications in Journal of Vitreoretinal Diseases
Baseline and 3-Year Follow-Up Changes in Retinal Neurovascular Structures Assessed by OCT and OCTA in Pediatric Type 1 Diabetes Without Retinopathy
Purpose: To investigate longitudinal changes in retinal neurovascular components over a 3-year period using optical coherence tomography (OCT) and OCT angiography (OCTA) in pediatric and adolescent individuals diagnosed with type 1 diabetes mellitus (DM) but without signs of diabetic retinopathy (DR). Methods: Individuals with type 1 DM and no clinical signs of DR were evaluated between May and September 2022. Quantitative evaluation was performed on neurovascular components of the retina in both the macular and peripapillary regions. Data from the previous 3 years (Group 1) were compared with current data (Group 2). Relationships between pubertal stage, duration of diabetes, and glycosylated hemoglobin (HbA 1c ) levels were examined. Results: The study included 92 eyes from 46 participants diagnosed with type 1 DM. Group 2 had significantly lower vessel densities in the foveal and parafoveal superficial capillary plexus and deep capillary plexus than Group 1. However, central foveal thickness (CFT), inner retinal thickness, peripapillary retinal nerve fiber layer thickness, and nasal inferior disc-vessel density were significantly higher in Group 2. A significant relationship was found between pubertal stage and vessel densities in both the superficial capillary plexus and optic disc regions. HbA 1c levels and diabetes duration correlated with the foveal avascular zone area and superficial capillary plexus/deep capillary plexus-vessel densities. Conclusions: Initially, the peripapillary microvascular structure is more affected than the macula in type 1 DM. However, after 3 years, microvascular macular decline becomes more prominent. Additionally, foveal retinal thickness and peripapillary retinal nerve fiber layer thickness were significantly increased.
- 26 March 2026
- Published by S. Karger AG in Molecular Syndromology
- p. 1-7
A Rare Cause of Thyroid Hormone Abnormalities in an Adolescent: A Case Report of SBP2 (SECISBP2) Deficiency
Introduction: Selenocysteine insertion sequence (SECIS)-binding protein 2 (SBP2) (SECISBP2) is essential for selenoprotein synthesis. Selenoproteins play critical roles in cellular redox homeostasis, antioxidant defense, and thyroid hormone metabolism. Deiodinases (DIOs) are selenoenzymes that catalyze the deiodination of iodothyronine and are important for thyroid hormone activation and inactivation. Mutations in SBP2, which facilitates the incorporation of selenium into selenoproteins, lead to defective production of DIOs. Case Presentation: A 13-year-and-6-month-old female patient presented with constipation and abnormal thyroid function tests. Laboratory tests revealed elevated free T4 (25.5 ng/L), normal TSH (1.2 mIU/L), low free T3 (2.3 ng/L), and decreased serum selenium level (14.37 μg/L). The patient exhibited speech and language delay, along with learning difficulties. These findings suggested SBP2 deficiency. Genetic analysis revealed a previously reported homozygous pathogenic variant, c.358C>T (p.Arg120Ter) in the SECISBP2 gene. Conclusion: This case highlights the importance of considering SBP2 deficiency in patients presenting with discordant thyroid function tests – namely, elevated free T4, low free T3, and normal TSH – especially when accompanied by neurological or developmental features such as speech delay and learning difficulties.
- 26 March 2026
- Published by S. Karger AG in Molecular Syndromology
- p. 1-7
A Rare Cause of Thyroid Hormone Abnormalities in an Adolescent: A Case Report of SBP2 (SECISBP2) Deficiency
Introduction: Selenocysteine insertion sequence (SECIS)-binding protein 2 (SBP2) (SECISBP2) is essential for selenoprotein synthesis. Selenoproteins play critical roles in cellular redox homeostasis, antioxidant defense, and thyroid hormone metabolism. Deiodinases (DIOs) are selenoenzymes that catalyze the deiodination of iodothyronine and are important for thyroid hormone activation and inactivation. Mutations in SBP2, which facilitates the incorporation of selenium into selenoproteins, lead to defective production of DIOs. Case Presentation: A 13-year-and-6-month-old female patient presented with constipation and abnormal thyroid function tests. Laboratory tests revealed elevated free T4 (25.5 ng/L), normal TSH (1.2 mIU/L), low free T3 (2.3 ng/L), and decreased serum selenium level (14.37 μg/L). The patient exhibited speech and language delay, along with learning difficulties. These findings suggested SBP2 deficiency. Genetic analysis revealed a previously reported homozygous pathogenic variant, c.358C>T (p.Arg120Ter) in the SECISBP2 gene. Conclusion: This case highlights the importance of considering SBP2 deficiency in patients presenting with discordant thyroid function tests – namely, elevated free T4, low free T3, and normal TSH – especially when accompanied by neurological or developmental features such as speech delay and learning difficulties.
- 24 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (3) , 297-302
The first report of a gross deletion in the SCNN1G gene in a case presenting with hyponatremic convulsion at fifth year of treatment
Objectives: Systemic pseudohypoaldosteronism type 1(PHA1) is a rare, autosomal recessive disorder resulting from loss-of-function mutations in epithelial sodium channel subunit genes. These mutations lead to aldosterone resistance in multiple tissues and typically manifest as hyponatremia, hyperkalemia, and metabolic acidosis. Case presentation: We report the case of a male infant with a history of severe neonatal hyponatremia and hyperkalemia. The case presented to our center with persistent electrolyte imbalances and treatment-resistant eczematous skin lesions. Initial sequencing of PHA1-associated genes ( SCNN1A , SCNN1B , and SCNN1G ) did not reveal any pathogenic variants. At the age of five, the case experienced a febrile seizure, during which laboratory related biochemical tests showed isolated hyponatremia with normokalemia. Further genetic work-up with high-resolution chromosomal microarray analysis was performed, revealing a novel homozygous gross deletion involving exons 2–3 of the SCNN1G gene. Conclusions: This is the first reported case of a homozygous gross deletion in the SCNN1G gene. This case expands the phenotypic and genotypic spectrum of systemic PHA1 and emphasizes the importance of considering copy number variants in genetically unresolved cases of PHA1, especially those presenting with atypical electrolyte profiles and extrarenal manifestations such as persistent eczema.
- 24 November 2025
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 39 (3) , 297-302
The first report of a gross deletion in the SCNN1G gene in a case presenting with hyponatremic convulsion at fifth year of treatment
Objectives: Systemic pseudohypoaldosteronism type 1(PHA1) is a rare, autosomal recessive disorder resulting from loss-of-function mutations in epithelial sodium channel subunit genes. These mutations lead to aldosterone resistance in multiple tissues and typically manifest as hyponatremia, hyperkalemia, and metabolic acidosis. Case presentation: We report the case of a male infant with a history of severe neonatal hyponatremia and hyperkalemia. The case presented to our center with persistent electrolyte imbalances and treatment-resistant eczematous skin lesions. Initial sequencing of PHA1-associated genes ( SCNN1A , SCNN1B , and SCNN1G ) did not reveal any pathogenic variants. At the age of five, the case experienced a febrile seizure, during which laboratory related biochemical tests showed isolated hyponatremia with normokalemia. Further genetic work-up with high-resolution chromosomal microarray analysis was performed, revealing a novel homozygous gross deletion involving exons 2–3 of the SCNN1G gene. Conclusions: This is the first reported case of a homozygous gross deletion in the SCNN1G gene. This case expands the phenotypic and genotypic spectrum of systemic PHA1 and emphasizes the importance of considering copy number variants in genetically unresolved cases of PHA1, especially those presenting with atypical electrolyte profiles and extrarenal manifestations such as persistent eczema.
- Open Access
- 31 January 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (4) , 387-395
Attitudes Towards the Management of Congenital Hypothyroidism in Türkiye: National Survey Study
Attitudes Towards the Management of Congenital Hypothyroidism in Türkiye: National Survey Study - Journal of Clinical Research in Pediatric Endocrinology
- 31 January 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (4) , 387-395
Open AccessAttitudes Towards the Management of Congenital Hypothyroidism in Türkiye: National Survey Study
Attitudes Towards the Management of Congenital Hypothyroidism in Türkiye: National Survey Study - Journal of Clinical Research in Pediatric Endocrinology
- Open Access
- 24 January 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (3) , 269-277
Current Practices in Hashimoto's Thyroiditis: Differences in Attitudes Between Pediatric and Adult Endocrinologists in Türkiye: A National Survey
Current Practices in Hashimoto's Thyroiditis: Differences in Attitudes Between Pediatric and Adult Endocrinologists in Türkiye: A National Survey - Journal of Clinical Research in Pediatric Endocrinology
- 24 January 2025
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (3) , 269-277
Open AccessCurrent Practices in Hashimoto's Thyroiditis: Differences in Attitudes Between Pediatric and Adult Endocrinologists in Türkiye: A National Survey
Current Practices in Hashimoto's Thyroiditis: Differences in Attitudes Between Pediatric and Adult Endocrinologists in Türkiye: A National Survey - Journal of Clinical Research in Pediatric Endocrinology
- Open Access
- 2 January 2024
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (1) , 23-30
Temporary Thyroid Dysfunction and Catecholamine Excess Due to Mercury Poisoning in 6 Cases
Objective: Mercury poisoning is a condition with multiple-organ dysfunction that has effects on the central nervous system, gastrointestinal system, cardiovascular system, skin, lungs, and kidneys. It can be fatal or may result in sequelae such as neurological disturbances, if treated late or left untreated. The endocrinological effects of mercury exposure are not well-known. We aimed to evaluate patients with mercury poisoning. Materials and Methods: A total of 6 cases of mercury poisoning from 3 families were included in the study. Clinical, laboratory, and follow-up data were recorded. Results: Thyroid dysfunction was presented as high thyroid hormones and normal thyrotropin level (unsuppressed) in 5 cases (83.3%). On the other hand, pheochromocytoma-like syndrome was detected in 5 cases (83.3%) with hypertension. The 4 cases were the first to use methimazole for mercury poisoning due to tachycardia and hypertension despite antihypertensive treatment due to catecholamine excess and thyroid dysfunction. Hyponatremia was detected in 3 cases (50%). Conclusion: Mercury poisoning is difficult to diagnose because it is rare and presents with nonspecific physical and laboratory findings. Early diagnosis and providing appropriate treatment are essential in order to prevent sequelae. Mercury poisoning should be considered in patients with unexplained hypertension and tachycardia suggesting the involvement of thyroid hormones and catecholamines Cite this article as: Özer Y, Yıldız M, Turan H, et al. Temporary thyroid dysfunction and catecholamine excess due to mercury poisoning in 6 cases. Turk Arch Pediatr. 2024;59(1):23-30.
- 2 January 2024
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 59 (1) , 23-30
Open AccessTemporary Thyroid Dysfunction and Catecholamine Excess Due to Mercury Poisoning in 6 Cases
Objective: Mercury poisoning is a condition with multiple-organ dysfunction that has effects on the central nervous system, gastrointestinal system, cardiovascular system, skin, lungs, and kidneys. It can be fatal or may result in sequelae such as neurological disturbances, if treated late or left untreated. The endocrinological effects of mercury exposure are not well-known. We aimed to evaluate patients with mercury poisoning. Materials and Methods: A total of 6 cases of mercury poisoning from 3 families were included in the study. Clinical, laboratory, and follow-up data were recorded. Results: Thyroid dysfunction was presented as high thyroid hormones and normal thyrotropin level (unsuppressed) in 5 cases (83.3%). On the other hand, pheochromocytoma-like syndrome was detected in 5 cases (83.3%) with hypertension. The 4 cases were the first to use methimazole for mercury poisoning due to tachycardia and hypertension despite antihypertensive treatment due to catecholamine excess and thyroid dysfunction. Hyponatremia was detected in 3 cases (50%). Conclusion: Mercury poisoning is difficult to diagnose because it is rare and presents with nonspecific physical and laboratory findings. Early diagnosis and providing appropriate treatment are essential in order to prevent sequelae. Mercury poisoning should be considered in patients with unexplained hypertension and tachycardia suggesting the involvement of thyroid hormones and catecholamines Cite this article as: Özer Y, Yıldız M, Turan H, et al. Temporary thyroid dysfunction and catecholamine excess due to mercury poisoning in 6 cases. Turk Arch Pediatr. 2024;59(1):23-30.
- Open Access
- 1 July 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (4) , 401-406
Thyroid Nodules in Children and Adolescents: A Single Institution’s Experience
Objective: The risk of malignancy in pediatric thyroid nodules is higher compared to the risk in adults. Our aim was to investigate the clinical, radiological, and histopathological characteristics of pediatric thyroid nodules. Materials and Methods: The data of 132 children and adolescents who had thyroid nodules were collected retrospectively from medical records. Results: The mean age of the patients was 12.07 ± 4.08 years and 67% were female. Fine-needle aspiration biopsy was performed in 86 patients (65%) and the results were as follows: benign in 53.4% (n = 46), atypia or follicular lesion of undetermined significance in 3.5% (n = 3), suspicious for follicular neoplasia in 2.3% (n = 2), and malignancy in 32.5% (n = 28). The overall malignancy rate was 22.7% (n = 30). Malignancy was detected after surgery in 2 thyroid nodules belonging to the atypia or follicular lesion of undetermined significance category. Malignancy was detected in 7 patients who had autoimmune thyroiditis and in 1 patient who had congenital dyshormonogenesis. The malignancy rate of the nodules in the patients, who had autoimmune thyroiditis, was found to be 13.4%. Mixed echogenicity, microcalcifications, nodules larger than 10 mm, abnormal lymph nodes, and irregular borders were more common in the malignant group. The nodule size, abnormal lymph nodes, and irregular borders were found to be significant in terms of predicting malignancy. Conclusion: We found malignancy in 22.7% of the thyroid nodules, and the malignancy rate of nodules in the patients, who had autoimmune thyroiditis, was 13.4%. The nodule size, abnormal lymph nodes, and irregular nodule borders emerged as the most significant risk factors for malignancy. Cite this article as: Dağdeviren Çakır A, Turan H, Ercan O, Evliyaoğlu O. Thyroid nodules in children and adolescents: A single institution’s experience. Turk Arch Pediatr. 2023;58(4):401-406.
- 1 July 2023
- Published by Caleo in Turkish Archives of Pediatrics
- Vol. 58 (4) , 401-406
Open AccessThyroid Nodules in Children and Adolescents: A Single Institution’s Experience
Objective: The risk of malignancy in pediatric thyroid nodules is higher compared to the risk in adults. Our aim was to investigate the clinical, radiological, and histopathological characteristics of pediatric thyroid nodules. Materials and Methods: The data of 132 children and adolescents who had thyroid nodules were collected retrospectively from medical records. Results: The mean age of the patients was 12.07 ± 4.08 years and 67% were female. Fine-needle aspiration biopsy was performed in 86 patients (65%) and the results were as follows: benign in 53.4% (n = 46), atypia or follicular lesion of undetermined significance in 3.5% (n = 3), suspicious for follicular neoplasia in 2.3% (n = 2), and malignancy in 32.5% (n = 28). The overall malignancy rate was 22.7% (n = 30). Malignancy was detected after surgery in 2 thyroid nodules belonging to the atypia or follicular lesion of undetermined significance category. Malignancy was detected in 7 patients who had autoimmune thyroiditis and in 1 patient who had congenital dyshormonogenesis. The malignancy rate of the nodules in the patients, who had autoimmune thyroiditis, was found to be 13.4%. Mixed echogenicity, microcalcifications, nodules larger than 10 mm, abnormal lymph nodes, and irregular borders were more common in the malignant group. The nodule size, abnormal lymph nodes, and irregular borders were found to be significant in terms of predicting malignancy. Conclusion: We found malignancy in 22.7% of the thyroid nodules, and the malignancy rate of nodules in the patients, who had autoimmune thyroiditis, was 13.4%. The nodule size, abnormal lymph nodes, and irregular nodule borders emerged as the most significant risk factors for malignancy. Cite this article as: Dağdeviren Çakır A, Turan H, Ercan O, Evliyaoğlu O. Thyroid nodules in children and adolescents: A single institution’s experience. Turk Arch Pediatr. 2023;58(4):401-406.
- 6 April 2023
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 36 (5) , 451-457
Comparative analyses of surrogates of metabolic syndrome in children and adolescents with metabolically healthy obesity vs. metabolically unhealthy obesity according to Damanhoury’s criteria
Objectives Metabolically healthy obesity (MHO) has been reported with varying frequencies in children. The reasons of metabolically healthy phenotype in some obese subjects are unclear. Our aim was to identify the frequency of MHO in obese subjects, to assess the potential associations of demographic characteristics, serum uric acid, alanine transaminase (ALT), pediatric nonalcoholic fatty liver disease fibsosis score probability (PNFS p) with MHO status and to evaluate the differences between MHO and metabolically unhealthy obesity (MUO) with regard to metabolic syndrome surrogates. Methods 251 consecutive obese subjects (125 females) aged 7–18 years were included. Subjects were classified as having MHO according to Damanhoury’s criteria. Several metabolic variables were measured, PNFS p was calculated by using the formula: z=1.1+(0.34*sqrt(ALT))+ (0.002*ALP)–(1.1*log(platelets)–(0.02*GGT). Results Median age of the subjects was 12.5 yr (range: 7.0–17.0 yr). The frequency of MHO was 41 %. Subjects with MHO were significantly younger, had lower waist circumference (WC) and waist height ratio (WHtR) and lower HOMA-IR than those without MHO(p<0.05 for all). Frequencies of hyperuricemia, hypertransaminasemia, hepatosteatosis and PNFS p values≥8 were similar betwen the groups. When putatively influential factors associated with MHO status were assessed with logistic regression analysis, only WC(β=1.03) and HOMA-IR(β=1.166) emerged as significant factors(Nagelkerke R2=0.142). None of the investigated demographic factors were associated with MHO status. Conclusions We found a remarkably high frequency of MHO status. Nevertheless, the absence of decreased frequencies of hyperuricemia, hypertransaminasemia and PNFS in subjects with MHO may suggest the need to reconsider the validity of the criteria defining MHO.
- 6 April 2023
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 36 (5) , 451-457
Comparative analyses of surrogates of metabolic syndrome in children and adolescents with metabolically healthy obesity vs. metabolically unhealthy obesity according to Damanhoury’s criteria
Objectives Metabolically healthy obesity (MHO) has been reported with varying frequencies in children. The reasons of metabolically healthy phenotype in some obese subjects are unclear. Our aim was to identify the frequency of MHO in obese subjects, to assess the potential associations of demographic characteristics, serum uric acid, alanine transaminase (ALT), pediatric nonalcoholic fatty liver disease fibsosis score probability (PNFS p) with MHO status and to evaluate the differences between MHO and metabolically unhealthy obesity (MUO) with regard to metabolic syndrome surrogates. Methods 251 consecutive obese subjects (125 females) aged 7–18 years were included. Subjects were classified as having MHO according to Damanhoury’s criteria. Several metabolic variables were measured, PNFS p was calculated by using the formula: z=1.1+(0.34*sqrt(ALT))+ (0.002*ALP)–(1.1*log(platelets)–(0.02*GGT). Results Median age of the subjects was 12.5 yr (range: 7.0–17.0 yr). The frequency of MHO was 41 %. Subjects with MHO were significantly younger, had lower waist circumference (WC) and waist height ratio (WHtR) and lower HOMA-IR than those without MHO(p<0.05 for all). Frequencies of hyperuricemia, hypertransaminasemia, hepatosteatosis and PNFS p values≥8 were similar betwen the groups. When putatively influential factors associated with MHO status were assessed with logistic regression analysis, only WC(β=1.03) and HOMA-IR(β=1.166) emerged as significant factors(Nagelkerke R2=0.142). None of the investigated demographic factors were associated with MHO status. Conclusions We found a remarkably high frequency of MHO status. Nevertheless, the absence of decreased frequencies of hyperuricemia, hypertransaminasemia and PNFS in subjects with MHO may suggest the need to reconsider the validity of the criteria defining MHO.
- 10 January 2023
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (5) , e660-e661
Prolonged Bleeding After Dental Extraction Due to Decreased Serum Level of Von Willebrand Factor Caused by Untreated Profound Hypothyroidism
Background: Delayed diagnosis of hypothyroidism may result in atypical presentations. Here, we report a case with decreased serum level and activity of von Willebrand factor due to untreated profound hypothyroidism Observation: A 9-year-old girl, presented with prolonged gingival bleeding after dental extraction. Clinical findings of the case were consistent with hypothyroidism, and the laboratory workup results revealed decreased serum level and activity of von Willebrand factor associated with profound hypothyroidism. Restoration of euthyroidism normalized the coagulation parameters. Conclusion: Delayed diagnosis of hypothyroidism may lead to atypical presentations such as bleeding diathesis. Profound hypothyroidism should be considered in the differential diagnosis of acquired von Willebrand disease to avoid undue treatment.
- 10 January 2023
- Published by Wolters Kluwer Health in Journal of Pediatric Hematology/Oncology
- Vol. 45 (5) , e660-e661
Prolonged Bleeding After Dental Extraction Due to Decreased Serum Level of Von Willebrand Factor Caused by Untreated Profound Hypothyroidism
Background: Delayed diagnosis of hypothyroidism may result in atypical presentations. Here, we report a case with decreased serum level and activity of von Willebrand factor due to untreated profound hypothyroidism Observation: A 9-year-old girl, presented with prolonged gingival bleeding after dental extraction. Clinical findings of the case were consistent with hypothyroidism, and the laboratory workup results revealed decreased serum level and activity of von Willebrand factor associated with profound hypothyroidism. Restoration of euthyroidism normalized the coagulation parameters. Conclusion: Delayed diagnosis of hypothyroidism may lead to atypical presentations such as bleeding diathesis. Profound hypothyroidism should be considered in the differential diagnosis of acquired von Willebrand disease to avoid undue treatment.